相关实验视频
Updated: Feb 22, 2026

12:17
IP-FCM: Immunoprecipitation Detected by Flow Cytometry
Published on: December 2, 2010
18.0K
关于抗体Fc工程的复杂专利情况
1Michalski Hüttermann, & Partner Patentanwälte mbB, Düsseldorf, Germany.
Journal of biotechnology
|February 20, 2026
概括
Fc域工程优化了抗体功能,但面临着复杂的专利. 本指南介绍了知识产权挑战,并提供了抗体研究和开发的策略.
科学领域:
- 生物化学和分子生物学
- 免疫学 免疫学 免疫学
- 知识产权法 知识产权法 知识产权法
背景情况:
- Fc域工程对于定制抗体效应器功能,药理动力学和结合策略至关重要.
- Fc工程的专利领域是复杂的,标志着不一致的命名法,重叠的权利要求和不断变化的专利术语.
研究的目的:
- 概述关键的Fc工程技术及其相关的知识产权考虑.
- 为在抗体研究和开发中的复杂专利环境中提供实用指导.
- 讨论行动自由评估的策略和监管影响.
主要方法:
- 审查Fc工程中的技术策略,包括Fcγ受体和FcRn亲和度调制.
- 分析常见的知识产权陷,使用代表性的专利例子.
- 讨论操作自由,许可和专利保护的实际方法.
主要成果:
- 确定关键的Fc工程技术及其专利挑战.
- 举例说明常见的知识产权陷及其对抗体研发的影响.
- 介绍导航专利问题的策略,包括许可和监管安全港.
结论:
- 有效的Fc领域工程需要仔细考虑复杂的专利环境.
- 对知识产权和操作自由的战略方法对于成功开发抗体至关重要.
- 了解监管条款是减轻涉及Fc工程的抗体研发风险的关键.
相关概念视频
Hybridoma Technology
17.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.9K
Antibody Actions
3.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.1K
Antibody Structure
65.9K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.9K
Drug Products: Biologics, Biosimilars and Interchangeables
298
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
298

